Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell Deficiency

Clinical trial NCT02577861 · COMPLETED

Trial details

NCT number: NCT02577861
Sponsor: Holostem s.r.l.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Limbal Stem Cells Deficiency

Start date: 2015-10-01
Primary completion: 2020-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.